{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:37:26Z","timestamp":1776836246758,"version":"3.51.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The soluble form of cellular prion protein (PrP\n                      <jats:sup>C<\/jats:sup>\n                      ) in plasma has been investigated as a biomarker in multiple conditions, yet its relationship with ischemic stroke severity remains unclear. Soluble PrP\n                      <jats:sup>C<\/jats:sup>\n                      is also implicated in immune-cell activation and inflammatory regulation. Here, we examined whether plasma soluble PrP\n                      <jats:sup>C<\/jats:sup>\n                      is associated with stroke severity and circulating CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cell immune responses in patients with acute ischemic stroke.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this single-center prospective cohort study, we consecutively enrolled patients with acute ischemic stroke admitted to the Department of Neurology, The First Hospital of Jilin University (Changchun, China) between June 2023 and October 2024 within 48\u00a0h of symptom onset (for wake-up stroke, onset was defined as the last known well). Fasting venous blood was collected the morning after admission. Stroke severity was categorized by admission NIHSS as mild (\u22646) or moderate-to-severe (&amp;gt;6), and volunteers from the Health Examination Center served as controls. Circulating CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells and Th1\/Th2\/Th17 subsets were quantified by flow cytometry, and soluble PrP\n                      <jats:sup>C<\/jats:sup>\n                      concentrations in plasma were measured by ELISA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Plasma soluble PrP\n                      <jats:sup>C<\/jats:sup>\n                      concentrations were higher in patients with ischemic stroke than in controls (1.16 [0.74, 1.99] ng\/mL vs 0.54 [0.36, 0.65] ng\/mL; P &amp;lt; 0.0001) and were further increased in the moderate-to-severe subgroup (1.91 [1.10, 3.18] ng\/mL vs 0.86 [0.58, 1.40] ng\/mL; P &amp;lt; 0.01). Plasma soluble PrP\n                      <jats:sup>C<\/jats:sup>\n                      was independently associated with admission NIHSS (B\u00a0=\u00a02.085, 95% CI 1.176-2.994; P &amp;lt; 0.001). Among stroke patients, plasma soluble PrP\n                      <jats:sup>C<\/jats:sup>\n                      was positively associated with Th2 proportion (\u03c1 = 0.73; P &amp;lt; 0.001) and negatively associated with the Th1\/Th2 ratio (\u03c1 = -0.66; P &amp;lt; 0.001); both associations remained significant after covariate adjustment (Th2: B\u00a0=\u00a01.504, 95% CI 1.166\u20131.841; Th1\/Th2: B = \u22122.374, 95% CI \u22123.427\u2013\u22121.322; both P &amp;lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Plasma soluble PrP\n                      <jats:sup>C<\/jats:sup>\n                      is elevated early after ischemic stroke and is associated with stroke severity and a Th2-skewed circulating CD4\n                      <jats:sup>+<\/jats:sup>\n                      T-cell profile. These findings support plasma soluble PrP\n                      <jats:sup>C<\/jats:sup>\n                      as a candidate acute-phase marker linked to post-stroke immune dysregulation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1801975","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:38:31Z","timestamp":1776832711000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma soluble cellular prion protein reflects ischemic stroke severity and is associated with circulating CD4+ T cell immune responses"],"prefix":"10.3389","volume":"17","author":[{"given":"Shuqin","family":"Hou","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguanliu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-020-00966-4","article-title":"Role of DAMPs and of leukocytes infiltration in ischemic stroke: insights from animal models and translation to the human disease","volume":"42","author":"Stanzione","year":"2020","journal-title":"Cell Mol Neurobiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI135530","article-title":"Immune responses to stroke: mechanisms, modulation, and therapeutic potential","volume":"130","author":"Iadecola","year":"2020","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.brainresbull.2023.03.005","article-title":"The role of T cells in acute ischemic stroke","volume":"196","author":"Wang","year":"2023","journal-title":"Brain Res Bull"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197058","article-title":"Cellular prion protein (PrPC): putative interacting partners and consequences of the interaction","volume":"21","author":"Miranzadeh Mahabadi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209272","article-title":"What are the roles of cellular prion protein in normal and pathologic conditions","volume":"102","author":"Benarroch","year":"2024","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2017.06.022","article-title":"Diverse functions of the prion protein \u2013 does proteolytic processing hold the key","volume":"1864","author":"Linsenmeier","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.913926","article-title":"Plasma PRPC levels correlate with severity and prognosis of intracerebral hemorrhage","volume":"13","author":"Wu","year":"2022","journal-title":"Front Neurol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2021.09.010","article-title":"Plasma cellular prion protein concentrations correlate with severity and prognosis of aneurysmal subarachnoid hemorrhage","volume":"523","author":"Yao","year":"2021","journal-title":"Clin Chim Acta"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2430-3","article-title":"The cellular prion protein is a stress protein secreted by renal tubular cells and a urinary marker of kidney injury","volume":"11","author":"Bignon","year":"2020","journal-title":"Cell Death Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000217262.03192.d4","article-title":"Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic Caspase-3 activation, and exacerbation of ischemic brain injury","volume":"37","author":"Weise","year":"2006","journal-title":"Stroke"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21142","article-title":"Cellular prion protein is increased in the plasma and peri \u2010 infarcted brain tissue after acute stroke","volume":"85","author":"Mitsios","year":"2006","journal-title":"J Neurosci Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63291-9","article-title":"Prion protein accumulation and neuroprotection in hypoxic brain damage","volume":"165","author":"McLennan","year":"2004","journal-title":"Am J Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1115-05.2005","article-title":"Overexpression of PrPC by Adenovirus-Mediated gene targeting reduces ischemic injury in a stroke rat model","volume":"25","author":"Shyu","year":"2005","journal-title":"J Neurosci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.09.030","article-title":"Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity","volume":"372","author":"Weise","year":"2004","journal-title":"Neurosci Lett"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071609","article-title":"Show me your friends and i tell you who you are: the many facets of prion protein in stroke","volume":"9","author":"Puig","year":"2020","journal-title":"Cells"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.382212","article-title":"Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts","volume":"18","author":"Matamoros-Angles","year":"2023","journal-title":"Neural Regener Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4110\/in.2013.13.4.148","article-title":"The soluble form of the cellular prion protein enhances phagocytic activity and cytokine production by human monocytes via activation of ERK and NF - \u03ba B","volume":"13","author":"Jeon","year":"2013","journal-title":"Immune Netw"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.06.172","article-title":"Activation of human natural killer cells by the soluble form of cellular prion protein","volume":"464","author":"Seong","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4049\/jimmunol.2100412","article-title":"A soluble PrPC derivative and Membrane-Anchored PrPC in extracellular vesicles attenuate innate immunity by engaging the NMDA-R\/LRP1 receptor complex","volume":"208","author":"Mantuano","year":"2022","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7754","DOI":"10.1038\/s41467-024-51931-4","article-title":"Prion protein alters viral control and enhances pathology after perinatal cytomegalovirus infection","volume":"15","author":"Karner","year":"2024","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-116087","article-title":"A role of cellular prion protein in programming T \u2010 cell cytokine responses in disease","volume":"23","author":"Ingram","year":"2009","journal-title":"FASEB J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51453","article-title":"Role of cellular prion protein in splenic CD4 + T cell differentiation in cerebral ischaemic\/reperfusion","volume":"8","author":"Zhang","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1089\/neu.2014.3471","article-title":"Primary Blast-Induced traumatic brain injury in rats leads to increased prion protein in plasma: a potential biomarker for Blast-Induced traumatic brain injury","volume":"32","author":"Pham","year":"2015","journal-title":"J Neurotrauma"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117286","article-title":"Plasma soluble prion protein, a potential biomarker for Sport-Related concussions: a pilot study","volume":"10","author":"Legname","year":"2015","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ebiom.2019.07.036","article-title":"The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer","volume":"46","author":"Le Corre","year":"2019","journal-title":"eBioMedicine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510577103","article-title":"Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.5.1556","article-title":"Prion protein expression in human leukocyte differentiation","volume":"91","author":"Dodelet","year":"1998","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(04)00029-8","article-title":"Prion protein is a component of the multimolecular signaling complex involved in T cell activation","volume":"560","author":"Mattei","year":"2004","journal-title":"FEBS Lett"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp298","article-title":"Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling","volume":"133","author":"Hu","year":"2010","journal-title":"Brain"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801975\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:38:34Z","timestamp":1776832714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801975\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2026.1801975"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1801975","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1801975"}}